It is important that as our committee crafts legislation on the opioid crisis, we give FDA clear authority to consider potential misuse and abuse of a product.
Gene Green: “It is important that as our committee crafts legislation on the opioid crisis, we give FDA clear authority to consider…”
Editor's note · Context
Stressing the need for FDA authority in opioid legislation.
Share
More from Gene Green
If the administration cares about accountability for 340B, perhaps they should start with implementing the delayed regulatory guidance program.
I hope we all agree on the importance of 340B and the need to stretch scarce federal resources as far as possible to reach more eligible patients and provide more comprehensive services.
Harris Health uses the savings from the program on patient care services which include the cost of treatment, administration, management of services and facilities, and improves access to quality health care for our community.
The Centers for Disease Control and Prevention reports that more than 700 women in the United States die each year due to complications related to pregnancy and childbirth.





